201 related articles for article (PubMed ID: 21075161)
21. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
22. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
[TBL] [Abstract][Full Text] [Related]
23. Dietary supplements in weight reduction.
Dwyer JT; Allison DB; Coates PM
J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S80-6. PubMed ID: 15867902
[TBL] [Abstract][Full Text] [Related]
24. HPLC-UV-QDa analysis of Citrus aurantium-labelled pre-workout supplements suggest only a minority contain the plant extract.
Koh AHW; Chess-Williams R; Lohning AE
J Pharm Biomed Anal; 2021 Jan; 193():113746. PubMed ID: 33190081
[TBL] [Abstract][Full Text] [Related]
25. Bitter orange weight loss products may not be safe.
Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
[No Abstract] [Full Text] [Related]
26. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
27. Effects of
Ruiz-Moreno C; Del Coso J; Giráldez-Costas V; González-García J; Gutiérrez-Hellín J
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467423
[TBL] [Abstract][Full Text] [Related]
28. Use of nonprescription dietary supplements for weight loss is common among Americans.
Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE
J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663
[TBL] [Abstract][Full Text] [Related]
29. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
Klontz KC; Timbo BB; Street D
Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
[TBL] [Abstract][Full Text] [Related]
30. Developmental toxicity of Citrus aurantium in rats.
Hansen DK; Juliar BE; White GE; Pellicore LS
Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):216-23. PubMed ID: 21594979
[TBL] [Abstract][Full Text] [Related]
31. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
Pellati F; Benvenuti S
J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
[TBL] [Abstract][Full Text] [Related]
32. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the cytotoxic, genotoxic, mutagenic, and pro-oxidant effect of synephrine, a component of thermogenic supplements, in human hepatic cells in vitro.
Ribeiro DL; Machado ART; da Silva Machado C; Santos PWDS; Aissa AF; Barcelos GRM; Antunes LMG
Toxicology; 2019 Jun; 422():25-34. PubMed ID: 31004705
[TBL] [Abstract][Full Text] [Related]
34. The Safety and Efficacy of
Koncz D; Tóth B; Bahar MA; Roza O; Csupor D
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235672
[TBL] [Abstract][Full Text] [Related]
35. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
Shara M; Stohs SJ; Smadi MM
Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
[TBL] [Abstract][Full Text] [Related]
36. p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties.
Stohs SJ; Shara M; Ray SD
Phytother Res; 2020 Aug; 34(8):1838-1846. PubMed ID: 32101364
[TBL] [Abstract][Full Text] [Related]
37. Actions of p-synephrine on hepatic enzyme activities linked to carbohydrate metabolism and ATP levels in vivo and in the perfused rat liver.
Maldonado MR; Bracht L; de Sá-Nakanishi AB; Corrêa RCG; Comar JF; Peralta RM; Bracht A
Cell Biochem Funct; 2018 Jan; 36(1):4-12. PubMed ID: 29270996
[TBL] [Abstract][Full Text] [Related]
38. Variant angina associated with bitter orange in a dietary supplement.
Gange CA; Madias C; Felix-Getzik EM; Weintraub AR; Estes NA
Mayo Clin Proc; 2006 Apr; 81(4):545-8. PubMed ID: 16610576
[TBL] [Abstract][Full Text] [Related]
39. Acute p-synephrine ingestion increases whole-body fat oxidation during 1-h of cycling at Fatmax.
Gutiérrez-Hellín J; Ruiz-Moreno C; Del Coso J
Eur J Nutr; 2020 Oct; 59(7):3341-3345. PubMed ID: 31691018
[TBL] [Abstract][Full Text] [Related]
40. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
